The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 10, 2015

Filed:

Nov. 30, 2012
Applicants:

Charles M. Perou, Carrboro, NC (US);

Philip S. Bernard, Salt Lake City, UT (US);

Torsten O. Nielsen, North Vancouver, CA;

Matthew J. Ellis, St. Louis, MO (US);

Joel S. Parker, Chapel Hill, NC (US);

Miguel Martin, Madrid, ES;

Eva Carrasco, Madrid, ES;

Rosalia Caballero, Madrid, ES;

Inventors:

Charles M. Perou, Carrboro, NC (US);

Philip S. Bernard, Salt Lake City, UT (US);

Torsten O. Nielsen, North Vancouver, CA;

Matthew J. Ellis, St. Louis, MO (US);

Joel S. Parker, Chapel Hill, NC (US);

Miguel Martin, Madrid, ES;

Eva Carrasco, Madrid, ES;

Rosalia Caballero, Madrid, ES;

Assignees:

The University of Utah Research Foundation, Salt Lake City, UT (US);

British Columbia Cancer Agency Branch, Vancouver, British Columbia, CA;

Washington University, St. Louis, MO (US);

The University of North Carolina at Chapel Hill, Chapel Hill, NC (US);

Bioclassifier, LLC, St. Louis, MO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01);
Abstract

The application describes methods for screening subjects with breast cancer to determine if the breast cancer will be responsive to a breast cancer therapy including a taxane or a taxane derivative. The application also describes methods for treating subjects with breast cancer by screening them for the likelihood of the effectiveness of treating the cancer with a therapy including a taxane or a taxane derivative and administering the therapy in subjects when it is found that a taxane or a taxane derivative is likely to be effective.


Find Patent Forward Citations

Loading…